Senior insider sale
Chief Medical Officer at DENALI THERAPEUTICS INC. — senior position signals high conviction
$3.32M
150K shares
What this filing means
HO CAROLE plans to sell 150K shares of DENALI THERAPEUTICS INC. valued at approximately $3.32M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/3/2026ACC: 0001950047-26-000895
Officer· Chief Medical Officer
Since Aug 2018
150K
Shares to sell
$3.32M
Approx. market value
150K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Exercise of options under a registered plan
Cash
2/2/2026
44.02KExercise of options under a registered plan
Cash
2/2/2026
22.04KExercise of options under a registered plan
Cash
2/2/2026
83.94KTotal acquired150K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/2/2026 | Exercise of options under a registered plan Cash | 44.02K | — |
2/2/2026 | Exercise of options under a registered plan Cash | 22.04K | — |
2/2/2026 | Exercise of options under a registered plan Cash | 83.94K | — |
| Total | 150K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
150K
Market value
$3.32M
2/3/2026
Total
Units
150K
Value
$3.32M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/3/2026 | 150K | $3.32M | NASDAQ | Planned |
| Total | 150K | $3.32M | ||